St. Jude Medical Buys VC-Backed Endosense

St. Jude Medical, a St.Paul, Minnesota-based provider of medical devices, said Monday that it has acquired Endosense for an initial payment of $170 million. St. Jude Medical will also pay an additional $161 million for the acquisition. BofA Merrill Lynch is serving as financial advisor to St. Jude Medical for the transaction while Perella Weinberg Partners is advising Endosense. Based in Geneva, Switzerland, Endosense, is a medical technology company focused on treating cardiac arrhythmias. It is backed by Edmond de Rothschild Investment Partners, NeoMed Management, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital Partners, Initiative Capital Romandie and NGN Capital.

DealsNorth AmericaUSBriefs